Jonathan E. Lim, President, CEO at HALOZYME THERAPEUTICS INC (HALO), sold 16,801 shares at $9.16 ($158K) on 2007-06-29, disclosed to the SEC on 2007-07-02.
Scheduled sale ($158k) by President, CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.16 | 100 | $916 | 0.6% |
| 2 | $9.17 | 100 | $917 | 0.6% |
| 3 | $9.18 | 100 | $918 | 0.6% |
| 4 | $9.23 | 200 | $2K | 1.2% |
| 5 | $9.24 | 100 | $924 | 0.6% |
| 6 | $9.26 | 300 |
| $3K |
| 1.8% |
| 7 | $9.27 | 200 | $2K | 1.2% |
| 8 | $9.28 | 100 | $928 | 0.6% |
| 9 | $9.30 | 800 | $7K | 4.7% |
| 10 | $9.32 | 600 | $6K | 3.5% |
| 11 | $9.33 | 900 | $8K | 5.3% |
| 12 | $9.36 | 1,100 | $10K | 6.5% |
| 13 | $9.37 | 600 | $6K | 3.5% |
| 14 | $9.38 | 600 | $6K | 3.6% |
| 15 | $9.39 | 300 | $3K | 1.8% |
| 16 | $9.39 | 1,960 | $18K | 11.6% |
| 17 | $9.40 | 286 | $3K | 1.7% |
| 18 | $9.41 | 681 | $6K | 4.0% |
| 19 | $9.48 | 400 | $4K | 2.4% |
| 20 | $9.49 | 100 | $949 | 0.6% |
| 21 | $9.50 | 1,100 | $10K | 6.6% |
| 22 | $9.51 | 2,000 | $19K | 12.0% |
| 23 | $9.51 | 100 | $951 | 0.6% |
| 24 | $9.52 | 1,374 | $13K | 8.3% |
| 25 | $9.52 | 100 | $952 | 0.6% |
| 26 | $9.53 | 500 | $5K | 3.0% |
| 27 | $9.54 | 200 | $2K | 1.2% |
| 28 | $9.54 | 700 | $7K | 4.2% |
| 29 | $9.55 | 1,200 | $11K | 7.2% |
| Total | $9.43 avg | 16,801 | $158K | 100% |
| Filing → |
| ERAS | BUY | 2023-06-08 | $275K | — | Filing → |
| ERAS | BUY | 2023-03-28 | $284K | — | Filing → |
| ERAS | BUY | 2023-01-10 | $232K | — | Filing → |